Trevi Therapeutics, Inc. TRVI Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$42.76M+10.8% | -$47.91M-64.8% | -$29.07M+0.3% | -$29.15M+14.1% | ||
| $144K-2.0% | $147K+19.5% | $123K+186% | $43K-14.0% | ||
| $5.19M+44.5% | $3.59M+65.2% | $2.17M-6.7% | $2.33M-8.5% | ||
| -$42.09M-10.0% | -$38.26M-20.6% | -$31.71M-12.5% | -$28.18M+2.7% | ||
| —— | —— | $137K— | —— | ||
| -$94.11M— | —— | $59.43M— | —— | ||
| $121.01M+96.8% | $61.48M— | —— | $111.31M+436% | ||
| -$15.18M-993% | $1.7M-91.4% | $19.81M+182% | -$24.24M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Trevi Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Trevi Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.